Liver Function's impact on drug processing examined in new trial
NCT ID NCT06957756
First seen Feb 21, 2026
Summary
This study tested how the drug BI 1584862 is handled by the body in people with different levels of liver function. 43 adults with mild, moderate, or severe liver problems, and some with healthy livers, took a single dose. Researchers measured drug levels in the blood and monitored safety to guide future dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
American Research Corporation
San Antonio, Texas, 78215, United States
-
Arizona Clinical Trials - Chandler
Chandler, Arizona, 85225, United States
-
Omega Research Orlando, LLC
Orlando, Florida, 32808, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BI 1584862
What this could lead to
If successful, this study could help doctors understand how to dose BI 1584862 safely for people with liver problems.
What could go wrong
This is an early-phase study with only 43 participants, so results may not apply to everyone. The drug is still being tested and may not work as expected.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.